← Back to All Filings

Encompass Health Director Greg D. Carmichael Receives Dividend Equivalent RSUs

Low SignificanceOctober 19, 2026 at 4:38:26 PM EDT

Encompass Health Corp

$EHC4CIK: 0000785161

Subscribe to track EHC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Encompass Health Corp ($EHC) - Form 4 Filing Analysis • Insider: Greg D. Carmichael (Director) • Transaction: Grant / Award (Dividend Equivalent RSUs) • Shares: +28 • Price: $0.00 (Market reference: $127.77) • Post-Transaction Holdings: 20,377 shares • Significance: Low (Routine dividend reinvestment into RSUs)

Comprehensive Analysis

Overview

On October 19, 2026, a Form 4 was filed for Encompass Health Corp ($EHC) reporting an equity award to Director Greg D. Carmichael.

Transaction Details

  • Date: October 15, 2026
  • Security: Encompass Health Common Stock
  • Shares Acquired: 28 shares / restricted stock units (RSUs)
  • Transaction Price: $0.00
  • Ownership After Transaction: 20,377 shares held directly
  • Transaction Code: 'A' (Grant, award, or other acquisition pursuant to an equity compensation plan)

Footnote Context

Per Footnote (1), the 28 additional RSUs were credited to Mr. Carmichael's account in connection with a quarterly cash dividend of $0.21 per share paid on October 15, 2026. Under the terms of the company's director award agreements, dividend equivalent units are credited based on the closing stock price on the dividend payment date ($127.77).

Analysis & Significance

This transaction carries Low trading significance. It is an automatic, formulaic dividend reinvestment adjustment to existing restricted stock units, rather than an open-market purchase or discretionary insider action.

Topics:#EncompassHealth#EHC#InsiderTrading#SECForm4#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.